(600 mg + 42 clinical trials

Randomized, Open-label, Single-Dose, Two-treatment, Two-period, Cross-over, Pivotal Bioequivalence Study Comparing Amoxicilin/Clavulanic acid powder for oral suspension 600 mg/42.9 mg/5 mL to Augmentin ES 600 mg/42.9 mg/5 mL powder for oral suspension in Healthy Adult Male and Female Volunteers under Fed Conditions.

This study compares a new liquid antibiotic to a well-known one. We want to see if the body handles both medicines in the exact same way when taken by healthy adults after eating. It helps make sure new versions of medicines work just as well.